Guidelines say metformin should be stopped where there is acute kidney injury or risk of renal compromise. Now there is evidence to support those recommendations.
Bobby Lazzara, MD
To image or not to image: A new study validates professional society recommendations on follow-up strategies for adrenal masses.
A randomized placebo controlled trial examined the effect of probiotics on gestational diabetes.
Patients were randomized to standard care, nurse-led education intervention, or nurse-led education plus acceptance therapy.
A meta-analysis compared the renal side effects of SGLT2 inhibitors in patients with type 2 diabetes.
A study compared mortality and major adverse cardiovascular events in patients with type 2 diabetes prescribed metformin or insulin.
Researchers compared time to onset of diabetes in a group of patients with obesity and pre-diabetes treated with liraglutide or placebo.
Research has shown the beneficial effects of empagliflozin on all-cause and CV mortality. Does the same hold true for another SGLT2 inhibitor?
The Qatar Study investigated the efficacy of exenatide plus pioglitazone versus basal-bolus insulin in poorly-controlled type 2 diabetes.
The authors compared biopsies of the duodenal mucosa in patients with type 1 diabetes, celiac disease, and controls.